Vu•Mesh™ vertebral body replacement system contains easy-to-use, biocompatible radiolucent implants to eliminate time-consuming cutting and contouring. The Vu•Mesh™ System is designed to increase the speed, ease and reliability of corpectomy by offering a variety of lengths in two popular footprints to accommodate a broad spectrum of patient anatomies.
Key Features
- Intraoperative flexibility with parallel or angulated endplates that support lordotic and kyphotic configurations
- Stackable implant spacers for heights down to 0.5mm increments
- Biocompatible, radiolucent PEEK-OPTIMA®
About Expandable Corpectomy Devices
Each year, there are more than 150,000 spinal fractures in North America*. There is an estimated 10,000 to 12,000 spinal cord injuries every year and approximately 39% of these injuries are cause by motor vehicle accidents4. These non-elective or trauma surgeries sometimes require additional spinal structural support which is when the Expandable Corpectomy Device are used.Another indication or use for these Devices is in the treatment of cancer patients. If the cancer metastasizes or spreads in the spine, the surgeon may opt to remove the affected vertebral bodies and replace them with an Expandable Corpectomy Device.*(http://emedicine.medscape.com/article/1264191-overview)
About SeaSpine
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide.